Oragenics, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Oragenics, Inc. on October 3, 2018, reporting events occurring through October 5, 2018. The filing details the full conversion of Series D Convertible Preferred Stock and the exercise of warrants issued during the company's July 2018 public offering.
Key Financial Metrics and Capital Structure
- Warrant Proceeds: The company received gross proceeds of $9,243,000 from the exercise of 9,243,000 Public Offering Warrants at an exercise price of $1.00 per share.
- Preferred Stock Conversion: All 1,496,000 shares of Series D Preferred Stock were voluntarily converted to common stock. No additional proceeds were received from these conversions.
- Common Stock Outstanding: As of October 5, 2018, the total common stock issued and outstanding is 29,158,135 shares.
- Other Metrics: The filing text does not provide clear values for revenue, profit, operating cash flow, margins, debt levels, or liquidity ratios.
Material Changes
The primary material change is the significant increase in outstanding common shares due to the full conversion of Series D Preferred Stock and the substantial exercise of warrants. This event altered the company's capital structure by eliminating the Series D Preferred class and increasing equity capital by $9.243 million.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future guidance, outlook, or specific risks. It is a factual report of capitalization events. No unusual items or contingencies were disclosed in this specific report.
Investor Verification Checklist
- Verify the updated share count of 29,158,135 in subsequent filings to confirm no further dilution or buybacks.
- Confirm the cash impact of the $9,243,000 warrant proceeds on the company's balance sheet in the next quarterly report.
- Review the terms of the July 2018 Public Offering to understand the remaining unexercised warrants (4,557,000 warrants remain unexercised based on the 13.8M issued minus 9.243M exercised).